JPS5955829A - 脳内の器質性障害に起因する精神機能症状の改善・治療剤 - Google Patents

脳内の器質性障害に起因する精神機能症状の改善・治療剤

Info

Publication number
JPS5955829A
JPS5955829A JP57165546A JP16554682A JPS5955829A JP S5955829 A JPS5955829 A JP S5955829A JP 57165546 A JP57165546 A JP 57165546A JP 16554682 A JP16554682 A JP 16554682A JP S5955829 A JPS5955829 A JP S5955829A
Authority
JP
Japan
Prior art keywords
brain
organic
improving
symptoms caused
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57165546A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0233689B2 (enExample
Inventor
Shizuo Kuriyama
栗山　鎮雄
Mikio Saito
斎藤　幹雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Mitsubishi Chemical Corp
Original Assignee
Eisai Co Ltd
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Mitsubishi Chemical Industries Ltd filed Critical Eisai Co Ltd
Priority to JP57165546A priority Critical patent/JPS5955829A/ja
Priority to US06/530,247 priority patent/US4507322A/en
Priority to DE8383109401T priority patent/DE3369640D1/de
Priority to IT22949/83A priority patent/IT1169837B/it
Priority to EP83109401A priority patent/EP0103897B1/en
Publication of JPS5955829A publication Critical patent/JPS5955829A/ja
Priority to US06/637,285 priority patent/US4576966A/en
Publication of JPH0233689B2 publication Critical patent/JPH0233689B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP57165546A 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤 Granted JPS5955829A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤
US06/530,247 US4507322A (en) 1982-09-22 1983-09-08 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
DE8383109401T DE3369640D1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
IT22949/83A IT1169837B (it) 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello
EP83109401A EP0103897B1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
US06/637,285 US4576966A (en) 1982-09-22 1984-08-03 Treatment of mental symptoms caused by organic disorder in brain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (2)

Publication Number Publication Date
JPS5955829A true JPS5955829A (ja) 1984-03-31
JPH0233689B2 JPH0233689B2 (enExample) 1990-07-30

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57165546A Granted JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Country Status (5)

Country Link
US (2) US4507322A (enExample)
EP (1) EP0103897B1 (enExample)
JP (1) JPS5955829A (enExample)
DE (1) DE3369640D1 (enExample)
IT (1) IT1169837B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6422847A (en) * 1987-07-16 1989-01-25 Mitsubishi Chem Ind Production of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153605A1 (en) * 1994-07-12 1996-01-13 Akihiro Tobe Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233658A (en) * 1975-09-10 1977-03-14 Mitsubishi Chem Ind Ltd Process for preparation of 2-(omega-aminoalkoxy)diphenylmethanes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154070C (da) * 1975-06-19 1989-02-27 Mitsubishi Chem Ind Analogifremgangsmaade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233658A (en) * 1975-09-10 1977-03-14 Mitsubishi Chem Ind Ltd Process for preparation of 2-(omega-aminoalkoxy)diphenylmethanes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6422847A (en) * 1987-07-16 1989-01-25 Mitsubishi Chem Ind Production of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride

Also Published As

Publication number Publication date
JPH0233689B2 (enExample) 1990-07-30
US4507322A (en) 1985-03-26
EP0103897B1 (en) 1987-02-04
DE3369640D1 (en) 1987-03-12
US4576966A (en) 1986-03-18
IT8322949A0 (it) 1983-09-21
EP0103897A1 (en) 1984-03-28
IT1169837B (it) 1987-06-03

Similar Documents

Publication Publication Date Title
CN108601751A (zh) 雷公藤红素的类似物
JP2012229261A (ja) 神経刺激性ステロイドの医薬組成物及びその使用
JP2022536017A (ja) 精神障害、行動障害、認知障害を処置する方法
JP2022507533A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
MX2024006271A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
WO2007046347A1 (ja) 筋萎縮性側索硬化症患者の運動神経保護用医薬
EP4606798A1 (en) Benzoisothiazole compound, and pharmaceutical composition and use thereof
JP4394686B2 (ja) 唾液分泌促進用医薬組成物およびその使用
CN104013638A (zh) 当药黄素及其衍生物的用途
JPS5955829A (ja) 脳内の器質性障害に起因する精神機能症状の改善・治療剤
DE69522764T2 (de) Verwendung vom einem Bicycloheptan-Derivat
WO1997024333A1 (en) Preventives/remedies for complications of diabetes
EP1535616B1 (en) Remedy for integration dysfunction syndrome
AU2024203992A1 (en) Prophylactic or therapeutic agent for porphyria
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
CN118632699A (zh) 用阿司匹林及其他非甾体抗炎药的高穿透性前药预防或治疗心血管疾病
KR20130124349A (ko) 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
TWI882128B (zh) 紫質症之預防或治療劑
RU2834322C1 (ru) Соли бензотиопиранонового соединения, способ их получения и применения
TW201032805A (en) Pharmaceutical compositions comprising a compound having suppressive effect on nutrient digestion or absorption and a cyclohexanecarboxamide derivative
JP6188784B2 (ja) 炎症性および免疫性疾患の治療のための組成物
CN112641765B (zh) 丙泊酚的抗疲劳制药用途
JPWO2001013911A1 (ja) 高血圧性細動脈障害抑制剤
KR102027176B1 (ko) 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
CN119326767A (zh) 用于治疗脏器纤维化相关疾病的药物组合物和方法

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees